Human cytomegalovirus (HCMV) is a widespread opportunistic pathogen that causes birth defects in newborns and severe disease in immunocompromised individuals. The broad tropism of HCMV infection suggests that it uses multiple receptors. We recently showed that the epidermal growth factor receptor (EGFR) serves as a receptor for HCMV. Here we show that HCMV also uses integrin αvβ3 as a coreceptor. Upon infection, HCMV glycoproteins gB and gH independently bind to EGFR and αvβ3, respectively, to initiate viral entry and signaling. αvβ3 then translocates to lipid rafts where it interacts with EGFR to induce coordinated signaling. The coordination between EGFR and αvβ3 is essential for the early events of HCMV infection, including viral entry, RhoA downregulation, stress-fiber disassembly and viral nuclear trafficking. Our findings support a model in which EGFR and αvβ3 work together as coreceptors for HCMV entry and signaling. This discovery is fundamental to understanding HCMV pathogenesis and developing treatment strategies targeted to viral receptors.
HCMV is a β-group herpesvirus that causes severe complications in immunocompromised individuals. HCMV is also a leading cause of virus-associated birth defects, is associated with atherosclerosis and coronary restenosis, and has been suggested as a cofactor in the progression of HIV-1 infection [1] [2] [3] [4] . The oncogenic potential of HCMV has also been shown [5] [6] [7] .
Identification of receptors for HCMV is essential for understanding HCMV pathogenesis, as these receptors are involved in mediating the immediate-early events necessary for infection. Many cell-surface components have been identified as virus receptors 8 , including signaling receptors such as chemokine receptor 9 , platelet-derived growth factor receptor 10 , fibroblast growth factor receptor 11 , EGFR 12 , tumor necrosis factor receptor family 13 and integrin 14 . Recently, we showed that EGFR is essential for HCMV binding, signaling and entry, and the HCMV envelope glycoprotein, gB, is the ligand for EGFR 15 .
Herpesviruses use multiple receptors, which may explain their broad tropism of infection 16 . Like other herpesviruses, the entry of HCMV into host cells occurs through a cascade of events that require interactions between cellular and viral molecules 16 . Pathological analyses of infected individuals indicate that HCMV can infect most major cell types. HCMV infection also triggers a variety of signaling cascades to elicit potent biological effects on host cells 15, 17, 18 .
HCMV disrupts actin stress fibers to facilitate infection 19 . Moreover, HCMV induces quiescent cells to re-enter G1 phase, which benefits viral DNA replication 20 . The rapid kinetics of these events suggest that they are regulated by receptor-mediated signaling. These events seem to be jointly regulated by growth factor receptors and integrins [21] [22] [23] . Although EGFR is capable of mediating these events, integrin is recognized as the essential element that links extracellular stimuli to the cytoskeleton and cell cycle regulators 21, [23] [24] [25] .
The interaction between different receptors on the plasma membrane is one mechanism responsible for coordination between signaling pathways 25 . Evidence suggests that lipid raft microdomains regulate the interaction between integrin and growth factor receptor 26 . These domains are docking sites for many signaling molecules, and are origins for coordinated signaling [27] [28] [29] . Many microbial pathogens, including viruses, use lipid rafts for entry, trafficking and budding 30, 31 . Here, we set out to determine whether integrin coordinates with EGFR to facilitate HCMV infection and whether lipid rafts are involved in this coordination.
RESULTS

Both EGFR and αvβ3 are required for HCMV infection
To determine whether integrins participate in HCMV infection, we performed infection-blocking experiments using function-blocking antibodies against various integrins. αvβ3-specific antibodies inhibited HCMV infection of human embryonic lung fibroblast (HEL) cells by 82%, (Fig. 1a) , whereas other isotype-matched antibodies against α1, α2, α3, α4, α5, α6, β1, β2, β4, αvβ5 and αvβ6 had no significant effect on infection (Fig. 1a and data not shown). When HCMV was preincubated with soluble αvβ3 molecules before infection, infectivity was inhibited by 77%; however, no inhibition was observed when HCMV was preincubated with αvβ5 (Fig. 1a) . The inhibitory effect of αvβ3 was neutralized by preincubation with αvβ3-specific antibody, suggesting specificity of inhibition (Fig. 1a) . Preincubation of cells with natural ligands of αvβ3 (Fig. 1a) blocked HCMV infectivity by 54% (vitronectin) and 23% (fibronectin). An RGD peptide, GRGDSP, did not block HCMV infection (Fig. 1a) , indicating that αvβ3-mediated infection depends on a ligand motif different from the typical tripeptide RGD motif. Consistent with our previous observation 15 , EGFR-specific antibody inhibited HCMV infection by 97% (Fig. 1a) .
Inhibition of infectivity by αvβ3-specific antibody was dose dependent (Fig. 1b) . Similar dose-dependent inhibition was also seen when HCMV and cells were preincubated with soluble αvβ3 and vitronectin or fibronectin, respectively (Fig. 1b) . These results suggest that integrin αvβ3 is involved in HCMV infection.
We searched for a correlation between viral gene expression and the presence of both EGFR and αvβ3 in various cell lines. We found that HCMV immediate-early proteins, IE1-72 and IE2-86, were expressed only in EGFR-and αvβ3-positive HEL and MB468 (human breast cancer) cells (Fig. 1c) . There was no detectable immediate-early protein expression in EGFR-negative cells, MB453 and Chinese hamster ovary (CHO) cells, nor in β3-negative human colorectal adenocarcinoma (SW480) cells. Transfection of an EGFR expression construct into αvβ3-positive, EGFR-negative MB453 (human breast cancer) cells rendered these cells susceptible to infection. High levels of immediate-early protein expression were detected in CHO cells after cotransfection with EGFR, αv expression plasmid and β3 expression plasmid. SW480 cells, from a β3-negative cell line that expresses a low level of EGFR 32 , were not susceptible to infection after transfection with the EGFR expression construct. However, SW480 cells became susceptible to infection when EGFR and β3 expression constructs were cotransfected. The same results were obtained when infection was performed at two different multiplicities of infection (MOI, 2 and 20 plaqueforming units (p.f.u.)/cell). In addition, levels of IE1-72 and IE2-86 were reduced substantially when the interaction between HCMV-EGFR or HCMV-αvβ3 was blocked by EGFR-neutralizing antibody (Fig. 1d) or soluble αvβ3, respectively. These data indicate that both EGFR and αvβ3 are required for HCMV infection.
EGFR and αvβ3 each interact with HCMV independently
To determine whether HCMV physically interacts with host cells through αvβ3, we incubated HEL cells with HCMV and quantified membrane-bound viruses by real-time DNA PCR 33 of cells with EGFR-and αvβ3-specific antibodies inhibited HCMV binding by 65% and 60%, respectively (Fig. 1e) . When the cells were pretreated with both antibodies, 94% of viral binding was inhibited (Fig. 1e) .
We used MB468 cells to monitor surface-bound particles by detecting HCMV capsid-associated protein UL94 through indirect immunofluorescence. Binding of HCMV to cells decreased when cells were pretreated with EGFR-or αvβ3-specific antibody (Fig. 1f) . When cells were pretreated with the combination of both antibodies, inhibition of HCMV binding was nearly complete (Fig. 1f) . Thus, HCMV can independently bind to target cells through both αvβ3 and EGFR.
HCMV activates PI3-K and Src signal pathways
To determine whether αvβ3 is activated upon HCMV infection, we assayed for phosphorylation of the β3 subunit in infected HEL cells (15 p.f.u./cell). HCMV induced tyrosine phosphorylation of β3 within 5 min after infection (Fig. 2a) . As reported previously 15 , HCMV induced phosphorylation of EGFR within 5 min after infection (Fig. 2a) . Concurrently, phosphoinositide 3-kinase (PI3-K) and Src, two downstream signaling molecules of EGFR and αvβ3, were activated after HCMV infection (Fig. 2a) .
Phosphorylation of the β3 and Src were induced by HCMV binding to αvβ3, as the phosphorylation of β3 and Src were inhibited when cells were infected with HCMV pretreated with soluble αvβ3 (Fig. 2b) or when cells were stably transfected with the β3-FF mutant plasmid 34 . Likewise, the phosphorylation of EGFR and p85 was inhibited when HCMV-induced EGFR activation was inhibited by EGFR-specific antibody (Fig. 2b) , or by AG1478 (100 nM), a specific inhibitor of EGFR kinase. HCMV induced only PI3-K signaling in β3-negative, EGFR-positive SW480 cells (Fig. 2c) . Only Src signaling was induced in EGFR-negative, αvβ3-positive MB453 cells. Both Src and PI3-K were activated when either MB453 or SW480 cells were converted to EGFR-and αvβ3-positive status. These results suggest that HCMVinduced PI3-K and Src signal pathways are mediated by EGFR and αvβ3, respectively.
HCMV gH is involved in the HCMV-αvβ3 interaction
The HCMV envelope protein gH has been suggested to be involved in signaling and fusion events during infection 35, 36 . We found that gH interacted with αvβ3, because both αv and β3 subunits were coimmunoprecipitated with gH (Fig. 2d) . The HCMV-αvβ3 interaction was disrupted by pretreating virus with gH-neutralizing antibody. An isotype-matched antibody directed against the envelope protein gB, which we thought may be involved in the interaction between HCMV and EGFR, could not disrupt this interaction. Subunits α1 and β5 were not coimmunoprecipitated by gH-specific antibody (Fig. 2d) . These data suggest that HCMV can specifically interact with αvβ3 through gH and that the gH-αvβ3 interaction is independent of the gB-EGFR interaction.
The gH-specific antibody blocked both αvβ3 and Src activation in HCMV-infected HEL cells (Fig. 2d) . Conversely, gB-specific antibody blocked both EGFR and p85 activation. These data suggest that HCMV activates EGFR-and αvβ3-mediated signaling pathways through gB and gH, respectively.
Crosstalk between EGFR-and αvβ3-mediated signaling As shown above, HCMV only infects cells expressing both EGFR and αvβ3, suggesting that cooperation between EGFR and αvβ3 is required. When HCMV-induced EGFR activation was inhibited by pretreating cells with EGFR-specific antibody (Fig. 2b) or AG1478, the β3 phosphorylation was also negatively affected (Fig. 2b) . Similarly, when activation of αvβ3 was inhibited by preincubating HCMV with soluble αvβ3 or by transfecting cells with a β3-FF construct, the EGFR phosphorylation was also affected. Src activation was inhibited profoundly by blocking EGFR activation, and PI3-K activation was inhibited by blocking αvβ3 activation. Similar results were observed when the activation of either αvβ3 or EGFR was inhibited by blocking the αvβ3-gH or EGFR-gB interaction, respectively (Fig. 2d) . These data suggest that there is crosstalk between EGFR and αvβ3 when both receptors are activated, which generates coordinated signaling and results in synergistic increases in both EGFR-and αvβ3-mediated signaling (Fig. 2b,d) .
Phosphorylation of β3 decreased substantially after pretreatment of cells with Ly294002 (Ly29, 20 µM), a specific PI3-K inhibitor (Fig. 2e) . The phosphorylation of EGFR decreased when cells were treated with PP2, a specific Src inhibitor (10 µM). The MAP kinase inhibitor U0126 had no effect on phosphorylation of either β3 or EGFR. We conclude that EGFR-dependent PI3-K and αvβ3-dependent Src signaling pathways coordinate after HCMV infection, leading to synergistic increases in downstream signaling.
EGFR-αvβ3 interaction is essential for signaling crosstalk
To determine whether HCMV induces an interaction between EGFR and αvβ3 and whether this leads to signaling coordination, we infected HEL cells with HCMV at 15 p.f.u./cell. EGFR coprecipitated with αvβ3 immunoprecipitated by αvβ3-specific antibody from lysates prepared 5 and 10 min after infection (Fig. 3a) . Conversely, αv and β3 subunits coprecipitated with EGFR immunoprecipitated with EGFR-specific antibody (Fig. 3a) . EGFR did not coprecipitate with αvβ5 (Fig. 3a) . The interaction between EGFR and αvβ3 was disrupted by inhibiting HCMV-induced activation of either EGFR or αvβ3 (Fig. 3b) , as well as by inhibition of Src by PP2 or PI3-K by Ly29 (Fig. 3b) . In similar assays, herpes simplex virus (HSV-1) did not induce an EGFR-αvβ3 interaction ( Supplementary Fig. 1 online) , suggesting that this interaction is specific to HCMV infection.
We compared data on complex formation (Fig. 3a,b) with data on signaling status (Fig. 2a,b) and found that substantial phosphorylation of EGFR, β3, PI3-K and Src occurred at 5 and 10 min, the same times when EGFR-αvβ3 complexes were seen. Inhibiting the formation of EGFR-αvβ3 complex by blocking either EGFR or αvβ3 activation resulted in much lower levels of αvβ3-and EGFR-mediated signaling (Fig. 2b,d ). These data suggest that the HCMV-induced EGFR-αvβ3 interaction, which occurs only when both receptors are activated, is required for the coordination between the two receptors.
Lipid rafts are involved in signal coordination
We examined whether lipid rafts regulate the HCMV-induced interaction between EGFR and αvβ3. Before infection, αvβ3 was located in nonraft fractions (Fig. 4a) and not in raft fractions (Fig. 4a) . Exposure to HCMV induced movement of αvβ3 molecules into lipid rafts after αvβ3 activation (Fig. 4a) . This translocation was not affected by EGFRspecific antibody or by AG1478 (data not shown), suggesting that the activation and translocation of αvβ3 to lipid rafts is independent of EGFR activation.
In uninfected cells, the majority of EGFR molecules were located in the raft fraction (Fig. 4a) . By 10 min after infection, the total level of EGFR in lipid rafts decreased substantially (Fig. 4a) , with a corresponding increase in nonraft regions (Fig. 4a) . These events were not inhibited by blocking the HCMVαvβ3 interaction (data not shown). Although HCMV induced movement of EGFR out of lipid rafts, a substantial level of phosphorylated EGFR localized with phosphorylated αvβ3 in the lipid raft fraction at 5 and 10 min after infection (Fig. 4a) . HCMV-induced EGFR-αvβ3 complex formation was detected within this time frame (Fig. 3a) , suggesting that lipid rafts regulate the interaction between EGFR and αvβ3.
EGFR was coprecipitated by αvβ3-specific antibody from raft fractions (5 min after infection) but not from nonraft fractions (Fig. 4b) . p85 also coprecipitated with αvβ3 only from raft fractions. Similarly, both β3 and Src were precipitated by EGFR-specific antibody only from raft fractions (Fig. 4b) . But when EGFR moved out of the lipid rafts (30 min after infection), EGFR and p85 no longer coprecipitated with αvβ3 from raft fractions (Fig. 4b) . Conversely, neither β3 nor Src were pulled down by EGFR-specific antibody after EGFR moved into nonraft regions (Fig. 4b) . These data suggest that EGFR and αvβ3 interact with each other to form a multimeric complex only when both receptors are colocalized in lipid raft microdomains. Notably, the HCMV-induced phosphorylation of EGFR, β3, p85 and Src were all reduced when cells were pretreated with methyl-β-cyclodextrin (MβCD, 5 mM, Fig. 4c) , a cholesterol-depleting drug that disrupts the integrity of lipid rafts 29 . Inhibition did not occur after MβCD was removed and cells were incubated with media containing cholesterol (30 µg/ml) before infection. We suggest that lipid rafts have an important role in the regulation of EGFR-αvβ3 interactions and, thereby, the coordination of EGFR-and αvβ3-dependent signaling pathways. 
PI3-K and Src signaling are required for HCMV entry
To determine whether coordination of EGFRand αvβ3-mediated signaling pathways is required for HCMV entry, we measured internalized viral DNA by real-time PCR. HCMV was internalized as early as 5 min after infection, and internalization reached a plateau at 30 min after infection. Internalization at 30 min after infection was inhibited by 96% after Ly29 treatment, by 74% after PP2 treatment and by 99% after MβCD treatment (Fig. 5a) . HCMV entry was also studied by monitoring the localization of the capsid-associated protein UL94 in MB468 cells under fluorescence microscopy. Most of the UL94 was internalized and had translocated into nuclei by 2 h after infection (Fig. 5b) . When cells were pretreated with Ly29, PP2 or MβCD, the majority of virus remained on the cell surface at 2 h after infection (Fig. 5b) . Thus, HCMV entry can be blocked when either EGFR-or αvβ3-dependent signaling is inhibited or when the integrity of lipid rafts is disrupted.
HCMV triggers downregulation of RhoA activity
Many viruses disrupt actin stress fibers to facilitate their nuclear translocation 30, 37 . The RhoA-cofilin pathway is primary regulator of the generation and maintenance of stress fibers 22, 38 . We found that levels of activated RhoA (GTP-RhoA) and total RhoA decreased considerably after HCMV infection (Fig. 6a) . Correspondingly, phosphorylation of cofilin, the downstream target of the RhoA 22 , decreased along with the decreased RhoA activity (Fig. 6a) . HCMV-induced reductions of active RhoA and total RhoA (Fig. 6b) were inhibited when infection was inhibited with EGFR-specific antibody, soluble αvβ3, Ly29, and PP2 (Fig. 6b) . Furthermore, when cells were treated with combinations of the inhibitors, EGFR-specific antibody + soluble αvβ3 and Ly29 + PP2, there was negligible reduction of RhoA. Phosphorylation of cofilin showed a similar pattern (Fig. 6b) . Real-time PCR was performed to quantify nuclear translocation of viral DNA at 2 h after infection. Addition of inhibitors reduced viral nuclear translocation (Fig. 6c) by 73% (Ly29), 55% (PP2), and 76% (Ly29 + PP2). The inhibition by Ly29 and PP2 could be relieved by the addition of Y-27632 (Ly29 + PP2 + Y27). These results suggest that signaling from both EGFR and αvβ3 are required for HCMV-induced downregulation of the RhoA-cofilin pathway.
Stress-fiber disruption and viral nuclear translocation
To determine whether actin stress fibers change structurally after HCMV-induced RhoA downregulation, we used Alexa Fluor 488-labeled phalloidin to visually monitor actin in infected HEL cells. By 5 and 30 min after infection, both the number and intensity of stress fibers had substantially decreased (Fig. 6d) , correlating with RhoAcofilin downregulation (Fig. 6a) . Movement of UL94 was also monitored through indirect immunofluorescence. During this period, UL94 entered cells and distributed throughout the cytoplasm (Fig. 6d) . At 2 h after infection, stress fibers were disrupted considerably, concomitant with nuclear translocation of UL94 (Fig. 6d) . These events were substantially inhibited by the treatment of cells with either Ly29 or PP2 (Fig. 6e) . The inhibition by Ly29 and PP2 could be reversed by addition of the RhoA inhibitor Y-27632 (Y27, 10 µM), as treatment of cells with the combination of Ly29, PP2 and Y27 led to both disruption of stress fibers and induction of nuclear translocation of UL94 (Fig. 6e) . There was a close temporal relationship between the disruption of stress fibers and nuclear translocation of UL94 (Fig. 6d,e) . Treatment of cells with cytochalasin B (5 µM), an actin-disrupting compound, led to a more rapid translocation of UL94, as early as 30 min after infection (Fig. 6e) . These data suggest that both HCMV-induced RhoA downregulation and disruption of stress fibers are essential for the nuclear translocation of HCMV. 
DISCUSSION
Many viruses require more than one receptor to facilitate infection 16, [39] [40] [41] . These receptors and their viral ligands usually form higher-order molecular complexes to generate coordinated signaling essential for the early events of infection, such as virus entry and trafficking 16, [42] [43] [44] . Receptors known to be involved in coordinated signaling include growth factor receptor and integrin 25 . The coordination between receptors is essential for the signaling required for various cellular events, including cell proliferation, differentiation and cell mobility 23 . In our study, HCMV simultaneously and independently bound to EGFR (through gB) and αvβ3 (through gH) and induced both EGFR-dependent PI3-K and αvβ3-dependent Src signaling. Coordination between these two signaling pathways existed, as there was increased activation of each individual pathway when both pathways were activated. An HCMV-induced interaction between EGFR and αvβ3 within lipid rafts was required for the coordinated signaling. Disruption of the EGFR-αvβ3 interaction and specific inhibition of the coordination between P3-K and Src inhibited viral entry. Furthermore, coordination between PI3-K and Src was needed for HCMV-induced RhoA downregulation, which was required for disruption of actin stress fibers and viral nuclear translocation. Notably, RhoA activity did not seem to be essential for early stages of viral entry ( Supplementary  Fig. 2 online) . HCMV activates distinct signaling pathways through αvβ3 and EGFR. Various cellular processes, such as embryonic development, tissue homeostasis and cell cycle progression of normal cells, are tightly regulated by both integrin-mediated adhesion to the extracellular matrix and the binding of growth factors to their receptors 25 . Therefore, it is probable that each distinct receptor has its own predominant means of mediating cognate signaling pathways, each with specific biological activities. A notable observation from our studies is that HCMV seems to induce coordination between EGFR-and αvβ3-mediated signaling pathways, and this coordination seems to be crucial for successful viral infection.
Our studies show that HCMV induces translocation of αvβ3 into lipid rafts, thus enabling a physical interaction between αvβ3 and EGFR. In fact, the EGFR-αvβ3 interaction, as well as the formation of a multimeric complex composed of EGFR, αvβ3 and their downstream signal molecules, Src and the p85 subunit of PI3-K, occurs only in lipid rafts. We conclude that the lipid rafts are involved in the regulation of the EGFR-αvβ3 interaction and, consequently, coordinated signaling.
Based on our findings, we propose a new model of HCMV infection ( Supplementary Fig. 3 online) in which HCMV membrane glycoproteins gB and gH bind EGFR and αvβ3 and trigger simultaneous activation of EGFR, αvβ3 and their respective signaling pathways. Activated EGFR and αvβ3 colocalize in lipid rafts, where they interact to form multimeric complexes that generate coordinated signaling. By this mechanism, HCMV is able to trigger potent, cooperative biological effects in target cells necessary for successful viral infection. We propose that HCMV entry occurs specifically within lipid rafts and not at random sites.
It has recently been shown that the integrin β1 subunit is also involved in HCMV infection 45 . Our preliminary data also indicate that β1 cooperates with EGFR to facilitate infection, but its efficiency is less than that of β3 ( Supplementary Fig. 4 online) . Whether β1 uses the same mechanism as αvβ3 to enhance infection needs to be investigated. According to our model, the broad tropism of HCMV primarily results from its ability to bind both EGFR and αvβ3. The ability to activate both EGFR and integrin may explain how HCMV elicits potent mitogenic activity. The coordinated signaling may also contribute to HCMV-induced cell migration, inflammatory responses and fibrosis that, for example, lead to restenosis 2 . In the case of our current study, identifying coreceptors that act synergistically will surely influence future treatment strategies for combating HCMV infection.
METHODS
Cells and virus. HEL, SW480, human breast cancer cells (MDA-MB453 and MDA-MB468) and CHO were obtained from American Type Culture Collection and cultured in Dulbecco Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) 15 . HEL cells transfected with pRcRSV-β3-FF plasmid were selected using G418. Towne strain HCMV (p38−40) was passaged and purified 46 and analyzed by electron microscopy and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Supplementary Fig. 5 online) . We used HCMV virions purified through a sucrose gradient for biological assays and virions purified through a CsCl gradient for binding and trafficking assays.
Plasmids, antibodies and reagents. See Supplementary Methods online.
Infection blocking assays. We preincubated HEL cells with function-blocking antibodies against various integrins (20 µg/ml) and EGFR (1 µg/ml), integrin ligands (40 µg/ml) or GRGDSP (200 µg/ml) in DMEM at 4 °C for 1 h. We washed the cells and infected them with virus at a MOI of 2 p.f.u./cell. We also infected cells with HCMV preincubated with soluble integrins (10 µg/ml), with or without neutralizing antibody treatment at 3 µg/ml. The cells were washed and covered with 1% methylcellulose in DMEM supplemented with 10% FBS and incubated at 37 °C until microplaques were visible. We fixed and stained monolayers with 0.8% Crystal violet in 50% ethanol. We counted plaques under an inverted microscope. Results are shown as percentages of inhibition as compared to that of control cells. The data were from three independent experiments performed in duplicate. For determination of viral gene expression, cells were pretreated with neutralizing antibodies or left untreated for 1 h before infection, and infected with HCMV (MOI of 2 p.f.u./cell) and harvested at 48 h after infection. In addition, we infected different cell lines as well as cells transfected with different plasmids expressing EGFR, αv subunit or β3 subunit with HCMV at a MOI of 2 and 20 p.f.u./cell, respectively. Viral immediate-early proteins were detected by immunoblotting.
Virus binding assays. The binding assays were performed by a method adapted from studies of Epstein-Barr virus 47 . HEL cells were fixed briefly with ice-cold 0.1% paraformaldehyde and incubated with HCMV virions for 1 h at 4 °C. Cells were washed and DNA molecules in HCMV particles remaining on the cell surface were released with lysis buffer (50 mM Tris-HCL, pH 8.0, 120 mM NaCl, 0.5% NP40). We determined the copy numbers of DNA in the lysates by real-time PCR 33, 48 . To block the binding of HCMV to cells, we preincubated the cells with neutralizing antibodies at 4 °C for 1 h.
Real-time DNA PCR. Real-time PCR was performed according to published procedures 48 . We used a pair of PCR primers (5´-GCTCCCCGAGCTCATTTTCA-3´ and 5´-CACAGCACGATGCCCACCA-3´) and a fluorescent probe FAM (5´-CACATACCCTACCGCCACGGCC-3´) TAMRA to determine the quantities of HCMV UL123 (IE1-72) gene in samples. Samples with known copy numbers of HCMV DNA were used as standards.
Virus entry assays.
We incubated HEL cells with HCMV at 4 °C for 1 h. Cells were washed and internalization was initiated by transferring the cells to 37 °C. HCMV remaining on the cell surface was removed by incubation with trypsin (100 µg/ml) for 5 min at 37 °C. We measured the quantity of internalized viral DNA by real-time PCR. Viral entry was blocked by preincubating cells with different compounds at 4 °C for 1 h.
Measurement of viral DNA in nuclei. After HCMV internalization, we isolated nuclei from HEL cells 18 after virions remaining on the surface were removed with trypsin. We quantified viral DNA in nuclei by real-time PCR. For trafficking-blocking assays, we incubated cells with HCMV at 37 °C for 5 min. The membrane-bound viruses were removed with trypsin. Cells were re-cultured with or without inhibitors at 37 °C for 2 h. Nuclei were isolated and viral DNA in the nuclei was measured. We verified the purity of nuclei by immunoblotting with GRP78-specific antibody 49 .
Isolation of caveolae or rafts. We isolated raft using a published method 50 . Briefly, cells were lysed in TNE buffer (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA) containing 1% Triton X-100 and adjusted to 40% sucrose using TNE containing 80% sucrose. We placed the lysates in an ultracentrifuge tube and overlaid them with 5-6 ml of TNE containing 38% sucrose and then with 2-3 ml of TNE containing 5% sucrose. The lysates were subjected to ultracentrifugation for 20 h at 35,000 rpm at 4 °C. We collected eight fractions and harvested the raft (fraction 3) and nonraft (fraction 8) fractions.
Immunofluorescence microscopy. We fixed cells in 4% paraformaldehyde and permeabilized them in 0.1% Triton X-100. The localization of UL94 was determined by incubation with antibody specific for UL94, followed by incubation with FITC-or rhodamine-labeled secondary antibody. For staining of actin stress fibers, we incubated samples with Alexa Fluor 488 phalloidin (Molecular Probes) according to the manufacturer's instructions. Nuclei were stained with 0.1% DAPI in phosphate-buffered saline. The cells were then mounted in Mowiol (Aldrich) and examined under an epifluorescence microscope (Zeiss Axioskop). We analyzed the images using the Openlab 3.0.7 Zeiss imaging system. Statistical analyses. All data are presented as mean ± s.d.
